Please Wait.....
Report
Depression Drugs Market Report by Drug Class (Atypical Antipsychotics, Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs), Selective Serotonin Reuptake Inhibitors (SSRIs), Central Nervous System (CNS) Stimulants, Tricyclic Antidepressants, Monoamine Oxidase Inhibitors, and Others), Disorder Type (Major Depressive Disorder, Obsessive-Compulsive Disorder, Generalized Anxiety Disorder, Panic Disorder, and Others), Drug Type (Generic Drugs, Branded Drugs), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others), and Region 2025-2033
Market Report I 2025-03-01 I 148 Pages I IMARC Group
The global depression drugs market size reached USD 19.2 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 25.1 Billion by 2033, exhibiting a growth rate (CAGR) of 2.9% during 2025-2033. The growing cases of depression among the masses due to sedentary lifestyle and stress, increasing advancements in drug formulation and delivery techniques, and rising preferences for digital therapeutics, such as mobile apps and online therapy platforms, are some of the factors impelling the market growth.
Depression is a mental disorder characterized by the absence of positive emotions, constant low mood and numerous cognitive, physical, behavioral and emotional symptoms. It is diagnosed by identifying the symptoms and checking the medical history of the patient. It is then treated using depression drugs, which balance the functioning of neurotransmitters, such as serotonin, in the brain and controlling the mood and emotions of the patient. These drugs can assist in relieving the signs of anxiety, seasonal affective disorder and dysthymia.
According to the World Health Organization (WHO), depression is one of the leading causes of disability and has impacted more than 264 million people across the globe. The increasing prevalence of mental disorders, such as social anxiety and depression, represents one of the key factors propelling the depression drugs market growth. Moreover, as governments of various countries have imposed complete lockdown and are promoting the adoption of social distancing measures, the everyday routine of a significant portion of the population has been altered, which, in turn, has negatively impacted the mental health of individuals. This trend has emerged as another major growth-inducing factor boosting the sales of depression drugs. Furthermore, the emergence of novel techniques for the development of antidepressants with minimal side-effects and long-term results, in confluence with the increasing acceptance of new medications, is anticipated to impel the market growth in the upcoming years.
IMARC Group's latest report provides a deep insight into the global depression drugs market covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter's five forces analysis, value chain analysis, etc. This report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the depression drugs market in any manner.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global and regional levels for 2025-2033. Our report has categorized the market based on drug class, disorder type, drug type, and distribution channel.
Breakup by Drug Class:
- Atypical Antipsychotics
- Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)
- Selective Serotonin Reuptake Inhibitors (SSRIs)
- Central Nervous System (CNS) Stimulants
- Tricyclic Antidepressants
- Monoamine Oxidase Inhibitors
- Others
Breakup by Disorder Type:
- Major Depressive Disorder
- Obsessive-Compulsive Disorder
- Generalized Anxiety Disorder
- Panic Disorder
- Others
Breakup by Drug Type:
- Generic Drugs
- Branded Drugs
Breakup by Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Others
Breakup by Region:
- North America
- Europe
- Asia Pacific
- Middle East and Africa
- Latin America
Competitive Landscape:
The report has also analyzed the competitive landscape of the market with some of the key players being Otsuka Pharmaceutical, Pfizer, Eli Lilly and Company, AstraZeneca, Novartis, Bristol-Myers Squibb, GlaxoSmithKline, Takeda Pharmaceutical Company, Allergan, Johnson & Johnson, Zhejiang NHU Company Ltd, Sebela Pharmaceuticals, etc.
Key Questions Answered in This Report
1.What is the size of the global depression drugs market?
2.What has been the impact of COVID-19 on the global depression drugs market?
3.What is the expected growth rate of the global depression drugs market?
4.What are the key factors driving the global depression drugs market?
5.What is the breakup of the global depression drugs market based on the disorder type?
6.What is the breakup of the global depression drugs market based on the distribution channel?
7.What are the key regions in the global depression drugs market?
8.Who are the key companies/players in the global depression drugs market?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Depression Drugs Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Breakup by Drug Class
5.5 Market Breakup by Disorder Type
5.6 Market Breakup by Drug Type
5.7 Market Breakup by Distribution Channel
5.8 Market Breakup by Region
5.9 Market Forecast
6 Market Breakup by Drug Class
6.1 Atypical Antipsychotics
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Selective Serotonin Reuptake Inhibitors (SSRIs)
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Central Nervous System (CNS) Stimulants
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Tricyclic Antidepressants
6.5.1 Market Trends
6.5.2 Market Forecast
6.6 Monoamine Oxidase Inhibitors
6.6.1 Market Trends
6.6.2 Market Forecast
6.7 Others
6.7.1 Market Trends
6.7.2 Market Forecast
7 Market Breakup by Disorder Type
7.1 Major Depressive Disorder
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Obsessive-Compulsive Disorder
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Generalized Anxiety Disorder
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Panic Disorder
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Others
7.5.1 Market Trends
7.5.2 Market Forecast
8 Market Breakup by Drug Type
8.1 Generic Drugs
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Branded Drugs
8.2.1 Market Trends
8.2.2 Market Forecast
9 Market Breakup by Distribution Channel
9.1 Hospital Pharmacies
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Retail Pharmacies
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Online Pharmacies
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Others
9.4.1 Market Trends
9.4.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Europe
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Asia Pacific
10.3.1 Market Trends
10.3.2 Market Forecast
10.4 Middle East and Africa
10.4.1 Market Trends
10.4.2 Market Forecast
10.5 Latin America
10.5.1 Market Trends
10.5.2 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porter's Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Otsuka Pharmaceutical
15.3.2 Pfizer
15.3.3 Eli Lilly and Company
15.3.4 AstraZeneca
15.3.5 Novartis
15.3.6 Bristol-Myers Squibb
15.3.7 GlaxoSmithKline
15.3.8 Takeda Pharmaceutical Company
15.3.9 Allergan
15.3.10 Johnson & Johnson
15.3.11 Zhejiang NHU Company Ltd
15.3.12 Sebela Pharmaceuticals
?Figure 1: Global: Depression Drugs Market: Major Drivers and Challenges
Figure 2: Global: Depression Drugs Market: Sales Value (in Billion USD), 2019-2024
Figure 3: Global: Depression Drugs Market: Breakup by Drug Class (in %), 2024
Figure 4: Global: Depression Drugs Market: Breakup by Disorder Type (in %), 2024
Figure 5: Global: Depression Drugs Market: Breakup by Drug Type (in %), 2024
Figure 6: Global: Depression Drugs Market: Breakup by Distribution Channel (in %), 2024
Figure 7: Global: Depression Drugs Market: Breakup by Region (in %), 2024
Figure 8: Global: Depression Drugs Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 9: Global: Depression Drugs Industry: SWOT Analysis
Figure 10: Global: Depression Drugs Industry: Value Chain Analysis
Figure 11: Global: Depression Drugs Industry: Porter's Five Forces Analysis
Figure 12: Global: Depression Drugs (Atypical Antipsychotics) Market: Sales Value (in Million USD), 2019 & 2024
Figure 13: Global: Depression Drugs (Atypical Antipsychotics) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 14: Global: Depression Drugs (Serotonin-Norepinephrine Reuptake Inhibitors) Market: Sales Value (in Million USD), 2019 & 2024
Figure 15: Global: Depression Drugs (Serotonin-Norepinephrine Reuptake Inhibitors) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 16: Global: Depression Drugs (Selective Serotonin Reuptake Inhibitors) Market: Sales Value (in Million USD), 2019 & 2024
Figure 17: Global: Depression Drugs (Selective Serotonin Reuptake Inhibitors) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 18: Global: Depression Drugs (Central Nervous System (CNS) Stimulants) Market: Sales Value (in Million USD), 2019 & 2024
Figure 19: Global: Depression Drugs (Central Nervous System (CNS) Stimulants) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 20: Global: Depression Drugs (Tricyclic Antidepressants) Market: Sales Value (in Million USD), 2019 & 2024
Figure 21: Global: Depression Drugs (Tricyclic Antidepressants) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 22: Global: Depression Drugs (Monoamine Oxidase Inhibitors) Market: Sales Value (in Million USD), 2019 & 2024
Figure 23: Global: Depression Drugs (Monoamine Oxidase Inhibitors) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 24: Global: Depression Drugs (Other Drug Classes) Market: Sales Value (in Million USD), 2019 & 2024
Figure 25: Global: Depression Drugs (Other Drug Classes) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 26: Global: Depression Drugs (Major Depressive Disorder) Market: Sales Value (in Million USD), 2019 & 2024
Figure 27: Global: Depression Drugs (Major Depressive Disorder) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 28: Global: Depression Drugs (Obsessive-Compulsive Disorder) Market: Sales Value (in Million USD), 2019 & 2024
Figure 29: Global: Depression Drugs (Obsessive-Compulsive Disorder) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 30: Global: Depression Drugs (Generalized Anxiety Disorder) Market: Sales Value (in Million USD), 2019 & 2024
Figure 31: Global: Depression Drugs (Generalized Anxiety Disorder) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 32: Global: Depression Drugs (Panic Disorder) Market: Sales Value (in Million USD), 2019 & 2024
Figure 33: Global: Depression Drugs (Panic Disorder) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 34: Global: Depression Drugs (Other Disorder Types) Market: Sales Value (in Million USD), 2019 & 2024
Figure 35: Global: Depression Drugs (Other Disorder Types) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 36: Global: Depression Drugs (Generic Drugs) Market: Sales Value (in Million USD), 2019 & 2024
Figure 37: Global: Depression Drugs (Generic Drugs) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 38: Global: Depression Drugs (Branded Drugs) Market: Sales Value (in Million USD), 2019 & 2024
Figure 39: Global: Depression Drugs (Branded Drugs) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 40: Global: Depression Drugs Market: Sales through Hospital Pharmacies (in Million USD), 2019 & 2024
Figure 41: Global: Depression Drugs Market Forecast: Sales through Hospital Pharmacies (in Million USD), 2025-2033
Figure 42: Global: Depression Drugs Market: Sales through Retail Pharmacies (in Million USD), 2019 & 2024
Figure 43: Global: Depression Drugs Market Forecast: Sales through Retail Pharmacies (in Million USD), 2025-2033
Figure 44: Global: Depression Drugs Market: Sales through Online Pharmacies (in Million USD), 2019 & 2024
Figure 45: Global: Depression Drugs Market Forecast: Sales through Online Pharmacies (in Million USD), 2025-2033
Figure 46: Global: Depression Drugs Market: Sales through Other Distribution Channels (in Million USD), 2019 & 2024
Figure 47: Global: Depression Drugs Market Forecast: Sales through Other Distribution Channels (in Million USD), 2025-2033
Figure 48: North America: Depression Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 49: North America: Depression Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 50: Europe: Depression Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 51: Europe: Depression Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 52: Asia Pacific: Depression Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 53: Asia Pacific: Depression Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 54: Middle East and Africa: Depression Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 55: Middle East and Africa: Depression Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 56: Latin America: Depression Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 57: Latin America: Depression Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Table 1: Global: Depression Drugs Market: Key Industry Highlights, 2024 and 2033
Table 2: Global: Depression Drugs Market Forecast: Breakup by Drug Class (in Million USD), 2025-2033
Table 3: Global: Depression Drugs Market Forecast: Breakup by Disorder Type (in Million USD), 2025-2033
Table 4: Global: Depression Drugs Market Forecast: Breakup by Drug Type (in Million USD), 2025-2033
Table 5: Global: Depression Drugs Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
Table 6: Global: Depression Drugs Market Forecast: Breakup by Region (in Million USD), 2025-2033
Table 7: Global: Depression Drugs Market Structure
Table 8: Global: Depression Drugs Market: Key Players
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security